103 related articles for article (PubMed ID: 11086419)
1. [Chemoradiotherapy with low-dose cisplatin and 5-FU for advanced esophageal cancer].
Tajima M; Ichikawa W; Takagi Y; Uetake Y; Kojima K; Osanai T; Takenaka S; Nihei Z; Sugihara K
Gan To Kagaku Ryoho; 2000 Oct; 27(12):1816-8. PubMed ID: 11086419
[TBL] [Abstract][Full Text] [Related]
2. [Immunohistochemical study of dihydropyrimidine dehydrogenase (DPD) and p53 in biopsied specimens of esophageal cancer before chemoradiotherapy].
Hisamitsu K; Fukuda K; Oka S; Yamaguchi K; Katano K; Ikeguchi M; Tsujitani S; Kaibara N
Gan To Kagaku Ryoho; 2001 Oct; 28(11):1527-9. PubMed ID: 11707971
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of p53 and 14-3-3sigma for the effect of chemoradiation therapy on esophageal squamous cell carcinoma.
Okumura H; Natsugoe S; Matsumoto M; Yokomakura N; Uchikado Y; Takatori H; Ishigami S; Takao S; Aikou T
J Surg Oncol; 2005 Jul; 91(1):84-9. PubMed ID: 15999354
[TBL] [Abstract][Full Text] [Related]
4. [Biochemical modulation of 5-FU--effect of low dose CDDP].
Hirata K; Yamamitsu S; Tsuji A; Shirasaka T; Mukaiya M; Oikawa I; Kimura H; Sasaki K; Denno R
Gan To Kagaku Ryoho; 1999 Mar; 26(4):467-75. PubMed ID: 10097743
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).
Ishida K; Ando N; Yamamoto S; Ide H; Shinoda M
Jpn J Clin Oncol; 2004 Oct; 34(10):615-9. PubMed ID: 15591460
[TBL] [Abstract][Full Text] [Related]
6. [Long-term results of chemoradiation therapy for the patients with locally advanced (T4) esophageal cancer].
Sekikawa K; Onogi H; Yazawa T; Sato Y; Sakamoto W; Miyamoto K; Fujita S; Suzuki S; Endo Y; Ohki S; Takenoshita S
Gan To Kagaku Ryoho; 2006 Sep; 33(9):1253-6. PubMed ID: 16969020
[TBL] [Abstract][Full Text] [Related]
7. [Preliminary clinical evaluation of continuous infusion of 5-FU and low-dose Cisplatin (LFP) therapy alone and combined with radiation therapy for treatment of advanced or recurrent esophageal cancer].
Itoh S; Morita S; Ohnishi T; Tsuji A; Takamatsu M; Horimi T
Gan To Kagaku Ryoho; 2002 Feb; 29(2):233-8. PubMed ID: 11865629
[TBL] [Abstract][Full Text] [Related]
8. Thymidylate synthase and dihydropyrimidine dehydrogenase are related to histological effects of 5-fluorouracil and cisplatin neoadjuvant chemotherapy for primary gastric cancer patients.
Fukuda H; Takiguchi N; Koda K; Oda K; Seike K; Miyazaki M
Cancer Invest; 2006; 24(3):235-41. PubMed ID: 16809149
[TBL] [Abstract][Full Text] [Related]
9. [Chemoradiotherapy using platinum analogs/5-FU for advanced esophageal cancer].
Shibata S; Kawasaki H; Nakai M; Morohashi H; Matsuya H; Yamada K; Morita T; Sasaki M
Gan To Kagaku Ryoho; 2002 Nov; 29(12):2209-12. PubMed ID: 12484039
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors after chemoradiotherapy for patients with inoperable esophageal squamous cell carcinoma.
Kunisaki C; Imada T; Yamada R; Hatori S; Kinbara K; Watai K; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono H; Shimada H
Hepatogastroenterology; 2006; 53(69):366-71. PubMed ID: 16795974
[TBL] [Abstract][Full Text] [Related]
11. [Usefulness of induction chemotherapy followed by chemo-radiotherapy for patients with advanced cervical esophageal cancer].
Suzuki T; Miura A; Kato T; Izumi Y; Monma K; Kawano T
Gan To Kagaku Ryoho; 2010 Jan; 37(1):71-5. PubMed ID: 20087035
[TBL] [Abstract][Full Text] [Related]
12. [Cost effectiveness of chemoradiotherapy with cisplatin/fluorouracil and nedaplatin/fluorouracil for patients with esophageal cancer].
Tomura K; Kogo M; Inoue T; Kaneko K; Imawari M; Yoneyama K; Kiuchi Y
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1807-13. PubMed ID: 18030014
[TBL] [Abstract][Full Text] [Related]
13. [Complete response in a case of advanced esophageal cancer treated by combined chemotherapy of TS-1 and CDDP with radiotherapy].
Nakarai K; Iwase H; Shimada M; Iyo T; Kaida S; Indou T; Doi R; Okeya M
Gan To Kagaku Ryoho; 2004 Feb; 31(2):229-31. PubMed ID: 14997757
[TBL] [Abstract][Full Text] [Related]
14. Prospective non-randomized trial comparing esophagectomy-followed-by-chemoradiotherapy versus chemoradiotherapy-followed-by-esophagectomy for T4 esophageal cancers.
Fujita H; Sueyoshi S; Tanaka T; Tanaka Y; Sasahara H; Shirouzu K; Suzuki G; Hayabuchi N; Inutsuka H
J Surg Oncol; 2005 Jun; 90(4):209-19. PubMed ID: 15906363
[TBL] [Abstract][Full Text] [Related]
15. [A case of advanced esophageal cancer responding remarkably to chemotherapy of TS-1 and weekly CDDP combined with radiotherapy].
Sakaguchi Y; Kabashima A; Yamamoto H; Shimabukuro R; Ojima Y; Yamamura S; Nishizaki T; Tashiro H; Matsusaka T
Gan To Kagaku Ryoho; 2004 Dec; 31(13):2159-62. PubMed ID: 15628763
[TBL] [Abstract][Full Text] [Related]
16. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
Hsu CH; Cheng AL; Hsu C; Yang CH; Lu YS; Lin CC; Bu CF; Yeh KH
Anticancer Res; 2002; 22(6B):3621-7. PubMed ID: 12552966
[TBL] [Abstract][Full Text] [Related]
17. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
18. [A case of advanced esophageal cancer showing good partial response by combination therapy of low dose 5-FU and low dose CDDP].
Akagi T; Sakata Y; Takemori H; Kimura S; Kudoh I; Suzuki H; Fukushi M; Aisawa T; Ishiguro Y; Yoshiike M; Osanai S
Gan To Kagaku Ryoho; 1996 Jan; 23(1):103-6. PubMed ID: 8546458
[TBL] [Abstract][Full Text] [Related]
19. Selective dose escalation of chemoradiotherapy for esophageal cancer: role of treatment intensification.
Seung SK; Smith JW; Molendyk J; Bader SB; Phillips M; Regan J; Louie J; Soo E; Seligman M; Ruzich J; Skokan L; Ross HJ
Semin Oncol; 2004 Dec; 31(6 Suppl 18):13-9. PubMed ID: 15726517
[TBL] [Abstract][Full Text] [Related]
20. [Three cases of advanced gastric cancer treated by TS-1 in combination with low-dose cisplatinum].
Gomi T; Ohtoshi M; Tamaki N; Momoi H; Kanaya S; Katayama T; Wada Y
Gan To Kagaku Ryoho; 2002 Feb; 29(2):301-4. PubMed ID: 11865638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
